Want to see GB:GEN full AI Analyst Report?
Top Page
Genuit Group
(LSE:GEN)
Select Model
Select Model
Rating:60Neutral
Price Target:
286.00 p
▼(-1.21% Downside)
Action:Downgraded
Date:03/12/26
The score is driven primarily by solid but not standout financial performance (better margins and earnings, but uneven revenue, rising leverage vs prior years, and weaker cash conversion). This is offset by weak technical momentum with the stock trading below key moving averages and bearish MACD/oscillators. Valuation and a ~3.24% dividend yield provide moderate support.
Positive Factors
Improving profitability
Sustained EBIT and net margin expansion to ~13.2% and ~7.5% indicates improving operational efficiency and pricing management. Higher margins bolster long-term profitability, provide a buffer against raw-material cost swings, and support reinvestment or shareholder returns over months.
Negative Factors
Choppy revenue trend
Intermittent top-line performance—declines then modest rebound—reduces visibility for capacity and investment planning. Persistent volatility in revenue undermines predictability of earnings, complicates long-term margin sustainability and makes capital allocation harder.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving profitability
Sustained EBIT and net margin expansion to ~13.2% and ~7.5% indicates improving operational efficiency and pricing management. Higher margins bolster long-term profitability, provide a buffer against raw-material cost swings, and support reinvestment or shareholder returns over months.
Read all positive factors
Genuit Group (GEN) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£720.18M
Dividend Yield3.19%
Average Volume (3M)678.36K
Price to Earnings (P/E)15.2
Beta (1Y)1.93
Revenue Growth7.27%
EPS Growth34.79%
CountryUK
Employees3,200
SectorIndustrials
Sector Strength72
IndustryConstruction
Share Statistics
EPS (TTM)0.18
Shares Outstanding252,177,830
10 Day Avg. Volume408,709
30 Day Avg. Volume678,359
Financial Highlights & Ratios
PEG Ratio0.47
Price to Book (P/B)1.23
Price to Sales (P/S)1.35
P/FCF Ratio12.36
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£402.40Price Target Upside39.00% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)0.25
Revenue Forecast (FY)£640.47M
Genuit Group Business Overview & Revenue Model
Company Description
Genuit Group plc, headquartered in Leeds, UK, is a developer and manufacturer of comprehensive water, climate, and ventilation management solutions. Founded in 1980 and previously known as Polypipe Group plc until its rebranding in April 2021, the...
How the Company Makes Money
Genuit Group makes money primarily by manufacturing and selling building-products systems—most notably plastic piping and ancillary components—into construction and infrastructure end-markets. Revenue is generated from (1) product sales of above-g...
Genuit Group Financial Statement Overview
Summary
Income Statement
72
Positive
Balance Sheet
67
Positive
Cash Flow
63
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 602.10M | 561.30M | 586.50M | 622.20M | 594.30M |
| Gross Profit | 250.60M | 249.70M | 245.80M | 247.60M | 239.00M |
| EBITDA | 122.60M | 107.20M | 102.00M | 92.00M | 104.20M |
| Net Income | 45.20M | 33.50M | 38.50M | 36.50M | 41.00M |
Balance Sheet | |||||
| Total Assets | 1.10B | 993.00M | 978.80M | 1.03B | 1.03B |
| Cash, Cash Equivalents and Short-Term Investments | 44.80M | 43.60M | 17.00M | 50.00M | 52.30M |
| Total Debt | 252.90M | 172.80M | 166.30M | 216.20M | 218.00M |
| Total Liabilities | 438.70M | 350.00M | 342.20M | 401.10M | 408.30M |
| Stockholders Equity | 662.90M | 643.00M | 636.60M | 627.10M | 617.70M |
Cash Flow | |||||
| Free Cash Flow | 65.80M | 79.50M | 63.10M | 43.10M | 40.30M |
| Operating Cash Flow | 93.40M | 105.10M | 97.60M | 86.90M | 74.90M |
| Investing Cash Flow | -133.20M | -27.90M | -28.50M | -44.00M | -270.50M |
| Financing Cash Flow | 40.90M | -50.60M | -102.10M | -45.20M | 203.90M |
Genuit Group Technical Analysis
Positive
289.50
Price Trends
263.76
Positive
290.95
Negative
310.16
Negative
Market Momentum
4.99
Negative
62.00
Neutral
79.08
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:GEN, the sentiment is Positive. The current price of 289.5 is above the 20-day moving average (MA) of 264.30, above the 50-day MA of 263.76, and below the 200-day MA of 310.16, indicating a neutral trend. The MACD of 4.99 indicates Negative momentum. The RSI at 62.00 is Neutral, neither overbought nor oversold. The STOCH value of 79.08 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:GEN.
Genuit Group Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £1.20B | 23.42 | 18.46% | 1.68% | 26.72% | 29.51% | |
70 Neutral | £530.40M | 13.78 | 20.94% | 5.91% | -3.52% | -10.90% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | £720.18M | 15.22 | 6.89% | 3.19% | 7.27% | 34.79% | |
58 Neutral | £108.90M | 11.68 | 9.23% | 3.97% | 12.74% | -3.35% | |
57 Neutral | £193.58M | 223.88 | 1.61% | 4.39% | -3.78% | -94.91% | |
53 Neutral | £260.67M | 873.53 | 0.15% | 3.48% | 6.87% | -91.28% |
* Industrials Sector Average
GB:GEN
Genuit Group
276.40
-99.39
-26.45%
GB:ECEL
Eurocell
112.00
-39.72
-26.18%
GB:JHD
James Halstead
125.00
-24.75
-16.53%
GB:NXR
Norcros
297.00
33.18
12.58%
GB:FAN
Volution
609.00
29.20
5.04%
GB:SRAD
Stelrad Group Plc
150.00
-2.58
-1.69%
Genuit Group Corporate Events
Regulatory Filings and Compliance
Genuit Non-Executive Director Increases Stake with £31,480 Share Purchase
Positive
Jun 2, 2026
Genuit Group plc disclosed that non-executive director and person discharging managerial responsibilities Shatish Dasani purchased 12,500 ordinary shares in the company on 2 June 2026. The transaction, executed on the London Stock Exchange at a pr...
Regulatory Filings and Compliance
Genuit Group Updates Market on Total Voting Rights
Neutral
May 29, 2026
Genuit Group has confirmed its current capital structure, stating that as of 29 May 2026 it has 252,178,198 ordinary shares of £0.001 each in issue, of which 375 are held in treasury. This leaves a total of 252,177,823 voting rights attached ...
Executive/Board ChangesRegulatory Filings and Compliance
Genuit Executives Exercise Deferred Share Awards in Routine Remuneration Move
Neutral
May 29, 2026
Genuit Group has disclosed that chief executive Joe Vorih and chief financial officer Tim Pullen have exercised nil-cost options granted under its Deferred Share Bonus Plan, which vested in April 2026. Vorih exercised rights over 22,764 shares and...
Regulatory Filings and Compliance
Genuit executives increase personal stakes with share purchases
Positive
May 27, 2026
Genuit Group has disclosed share purchases by two senior insiders, in line with UK Market Abuse Regulation rules on transparency for transactions by persons discharging managerial responsibilities. The company reported that Chief Financial Officer...
Business Operations and StrategyExecutive/Board ChangesStock BuybackDividendsShareholder Meetings
Genuit shareholders back all AGM resolutions and approve 8.7p dividend
Positive
May 22, 2026
Genuit Group plc said all resolutions at its 22 May annual general meeting in Leeds were approved, including the receipt of 2025 accounts, the directors’ remuneration report, and the declaration of a final dividend of 8.7 pence per share. Sh...
Business Operations and StrategyFinancial Disclosures
Genuit holds revenue steady amid cost pressures and eyes structural growth
Negative
May 22, 2026
Genuit Group reported that group revenue for the four months to 30 April 2026 was broadly flat at £198.5m, as lower market volumes, persistent wet weather and cost inflation in polymers and freight offset benefits from price rises. The Climat...
Executive/Board ChangesRegulatory Filings and Compliance
Genuit awards deferred share options to CEO and CFO under 2024 bonus plan
Neutral
May 5, 2026
Genuit Group plc has granted nil-cost options over ordinary shares to its chief executive officer, Joe Vorih, and chief financial officer, Tim Pullen, under its 2024 Deferred Share Bonus Plan in line with its approved remuneration policy. The awar...
Regulatory Filings and Compliance
Genuit CEO Increases Stake After Exercising Deferred Share Bonus Options
Neutral
May 1, 2026
Genuit Group plc disclosed that chief executive officer Joe Vorih has exercised a nil-cost option over 6,263 ordinary shares under the company’s Deferred Share Bonus Plan, relating to an award originally granted in April 2023 and vested in A...
Business Operations and StrategyPrivate Placements and Financing
Genuit Issues 2.5 Million New Shares to Fund Employee Incentive Plans
Neutral
Apr 30, 2026
Genuit Group has admitted 2.5 million new ordinary shares of £0.001 each to trading on the London Stock Exchange Main Market, taking its total shares in issue to 251,903,686, including a small number held in treasury. The new shares, admitted...
Regulatory Filings and Compliance
Genuit Group Updates Total Voting Rights and Share Capital
Neutral
Apr 30, 2026
Genuit Group plc has confirmed that as of 30 April 2026 it has 251,903,686 ordinary shares in issue, with 375 held in treasury, resulting in 251,903,311 total voting rights attached to its issued share capital. The updated share and voting rights ...
Executive/Board ChangesRegulatory Filings and Compliance
Genuit Executives Exercise Long-Term Incentive Share Options
Neutral
Apr 30, 2026
Genuit Group has disclosed that chief executive officer Joe Vorih and chief strategy and sustainability officer Martin Gisbourne have exercised nil-cost options over 26,034 and 5,055 ordinary shares, respectively, under the company’s long-te...
Executive/Board ChangesRegulatory Filings and Compliance
Genuit Grants Long-Term Nil-Cost Share Options to Senior Leadership
Neutral
Apr 14, 2026
Genuit Group has granted nil-cost share options under its Long Term Incentive Plan to executive directors and several senior managers for the financial year starting 1 January 2026. Awards to chief executive Joe Vorih and chief financial officer T...
Financial DisclosuresRegulatory Filings and ComplianceShareholder Meetings
Genuit Group Publishes 2025 Annual Report and Sets Date for 2026 AGM
Positive
Apr 14, 2026
Genuit Group has published its Annual Report and Accounts for the year ended 31 December 2025 and the notice of its 2026 Annual General Meeting, making both documents available via the UK National Storage Mechanism and its corporate website for sh...
Business Operations and StrategyDelistings and Listing Changes
Genuit Group Seeks Admission of 2 Million Shares for Incentive Plans
Neutral
Apr 10, 2026
Genuit Group has applied for the admission to trading of 2,000,000 new ordinary shares of £0.001 each on the London Stock Exchange to service its various share-based incentive and savings schemes. The shares, expected to be admitted on 15 Apr...
Business Operations and StrategyRegulatory Filings and Compliance
Genuit Strategy Chief Buys Shares in Regulatory-Disclosed Deal
Positive
Apr 1, 2026
Genuit Group has disclosed that its Chief Strategy and Sustainability Officer, Martin Gisbourne, has purchased 4,000 ordinary shares in the company on the London Stock Exchange. The transaction, executed on 30 March 2026 at a price of £2.8456...
Regulatory Filings and Compliance
Genuit Group Updates Share Capital and Total Voting Rights
Neutral
Mar 31, 2026
Genuit Group has reported its latest capital structure, confirming that as of 31 March 2026 it has 251,832,839 ordinary shares in issue, of which 375 are held in treasury, leaving 251,832,464 voting rights attached to the outstanding share capital...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.